Introduction: Numerous clinical trials have demonstrated the efficacy of treatment with pegylated interferon and ribavirin but little is known about the results obtained in clinical practice.
Objective: To evaluate treatment response and factors influencing the treatment of chronic hepatitis C in clinical practice.
Material And Methods: Between August 2001 and December 2005, we treated 219 patients with pegylated interferon (alpha 2a -fixed dose, or alpha 2b, according to weight) and ribavirin.